Page 28 - Michael Erman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(Reuters) -Merck & Co reported better-than-expected fourth-quarter results on Thursday on strong sales of its cancer immunotherapy Keytruda, now the world's biggest selling prescription medicine. Keytruda sales rose 21% to $6.6 billion as the company was able to increase use of the drug in earlier stage cancers, topping analyst forecasts of $6.5 billion. For the full year, Keytruda generated $25 billion, surpassing sales of AbbVie's blockbuster arthritis drug Humira at its peak.

Pfizer on Tuesday reported a surprise quarterly profit, as COVID products demand was better than the company's expectations and lower research costs. The U.S. drugmaker earned 10 cents...

(Reuters) -Pfizer reported a surprise quarterly profit on Tuesday, helped by cost-cutting measures and fewer returns of its COVID treatment Paxlovid by the U.S. government than it had expected, but revenue fell short of Wall Street estimates. Investors fled Pfizer last year as pandemic worries declined and billions of dollars in COVID-19 vaccine and treatment sales disappeared. Overall revenue in the quarter was $14.25 billion, shy of Wall Street estimates of $14.42 billion.

Pharmaceutical companies are due to receive by Thursday the U.S. government's opening proposal for discounts it is seeking on 10 high-cost medicines, an important step in the Medicare health program's...

Pharmaceutical companies are due to receive by Thursday the U.S. government's opening proposal for what are expected to be significant discounts on 10 of its high-cost medicines, an important step in...